First Trust Direct Indexing’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $521K | Sell |
|
|||||
|
2024
Q2 | $715K | Buy |
|
|||||
|
2024
Q1 | $397K | Sell |
|
|||||
|
2023
Q4 | $555K | Buy |
|
|||||
|
2023
Q3 | $453K | Buy |
|
|||||
|
2023
Q2 | $450K | Buy |
|
|||||
|
2023
Q1 | $458K | Sell |
|
|||||
|
2022
Q4 | $587K | Buy |
|
|||||
|
2022
Q3 | $440K | Sell |
|
|||||
|
2022
Q2 | $347K | Sell |
|
|||||
|
2022
Q1 | $473K | Buy |
|
|||||
|
2021
Q4 | $371K | Buy |
|
|||||
|
2021
Q3 | $397K | Buy |
|
|||||
|
2021
Q2 | $329K | Sell |
|
|||||
|
2021
Q1 | $301K | Hold |
|
|||||
|
2020
Q4 | $277K | Buy |
|